Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 7/20 | 0.34 |
| ▸ | ALOX12 | P18054 | 6/20 | 0.34 |
| ▸ | LMNA | P02545 | 5/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.33 |
| ▸ | HTT | P42858 | 2/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.32 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.32 |
| ▸ | KIT | P10721 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 4/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.31 |
| ▸ | MAPT | P10636 | 3/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27223517 | 0.92 | ALOX12 (0.34) | ALDH1A1NPSR1ALOX12LMNACYP1A2 | |
| SCHEMBL27224036 | 0.78 | ATM (0.35) | ALDH1A1NPSR1ALOX12LMNACYP1A2 | |
| SCHEMBL31603795 | 0.77 | ALOX12 (0.34) | ALDH1A1NPSR1ALOX12LMNACYP1A2 | |
| SCHEMBL27223416 | 0.76 | ALOX15 (0.34) | NPSR1LMNACYP1A2CYP3A4CYP2C9 | |
| SCHEMBL30749311 | 0.76 | ALOX15 (0.34) | NPSR1LMNACYP1A2CYP3A4CYP2C9 | |
| SCHEMBL31556691 | 0.75 | ALDH1A1 (0.51) | ALDH1A1NPSR1ALOX12LMNACYP1A2 | |
| SCHEMBL27223633 | 0.74 | P2RY12 (0.36) | ALDH1A1NPSR1ALOX12LMNACYP1A2 | |
| SCHEMBL30749322 | 0.74 | ALDH1A1 (0.35) | ALDH1A1NPSR1ALOX12LMNACYP1A2 | |
| SCHEMBL27223550 | 0.74 | ALDH1A1 (0.35) | ALDH1A1NPSR1ALOX12LMNACYP1A2 | |
| SCHEMBL31603763 | 0.73 | MDM2 (0.32) | ALDH1A1NPSR1ALOX12LMNACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4573096-A1 | INHIBITORS OF MYELOPEROXIDASE | Astrazeneca AB (SE) | 2025-06-25 | — | — | EP | disclosed |
| US-20240166642-A1 | INHIBITORS OF MYELOPEROXIDASE | ASTRAZENECA AB (SE) | 2024-05-23 | — | — | US | disclosed |
| WO-2024038131-A1 | INHIBITORS OF MYELOPEROXIDASE | ASTRAZENECA AB (SE) | 2024-02-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240166642-A1 | INHIBITORS OF MYELOPEROXIDASE | MPO, XDH, EPX | ALDH1A1 502/4885NPSR1 1532/4885ALOX12 775/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.